BRUNELLI, Matteo
 Distribuzione geografica
Continente #
EU - Europa 23.174
NA - Nord America 19.272
AS - Asia 12.740
SA - Sud America 2.072
AF - Africa 330
OC - Oceania 36
Continente sconosciuto - Info sul continente non disponibili 15
Totale 57.639
Nazione #
US - Stati Uniti d'America 18.664
RU - Federazione Russa 9.422
CN - Cina 4.604
SG - Singapore 4.601
GB - Regno Unito 4.493
IT - Italia 2.423
BR - Brasile 1.715
SE - Svezia 1.427
HK - Hong Kong 1.403
DE - Germania 1.369
IE - Irlanda 1.090
FR - Francia 1.041
FI - Finlandia 830
VN - Vietnam 779
CA - Canada 417
KR - Corea 355
UA - Ucraina 224
NL - Olanda 219
JP - Giappone 185
IN - India 145
TR - Turchia 140
AR - Argentina 135
MX - Messico 125
ES - Italia 114
PL - Polonia 114
BE - Belgio 112
BD - Bangladesh 93
ID - Indonesia 84
ZA - Sudafrica 83
AT - Austria 70
EC - Ecuador 69
LT - Lituania 63
TG - Togo 61
IQ - Iraq 54
BJ - Benin 52
CO - Colombia 42
MA - Marocco 35
PK - Pakistan 32
PY - Paraguay 30
AU - Australia 29
CZ - Repubblica Ceca 29
AE - Emirati Arabi Uniti 27
VE - Venezuela 26
IR - Iran 25
UZ - Uzbekistan 25
CL - Cile 24
EG - Egitto 21
KE - Kenya 19
AZ - Azerbaigian 18
JO - Giordania 17
LV - Lettonia 15
CH - Svizzera 14
PE - Perù 14
SA - Arabia Saudita 14
IL - Israele 13
KZ - Kazakistan 12
TN - Tunisia 12
BG - Bulgaria 11
DO - Repubblica Dominicana 11
PH - Filippine 11
HN - Honduras 10
HU - Ungheria 10
JM - Giamaica 10
NP - Nepal 10
PS - Palestinian Territory 10
UY - Uruguay 10
AM - Armenia 9
MY - Malesia 9
PA - Panama 9
CI - Costa d'Avorio 8
DK - Danimarca 8
DZ - Algeria 8
EU - Europa 8
GR - Grecia 8
KG - Kirghizistan 8
LK - Sri Lanka 8
PT - Portogallo 8
TW - Taiwan 8
AL - Albania 7
IM - Isola di Man 6
LA - Repubblica Popolare Democratica del Laos 6
RO - Romania 6
BO - Bolivia 5
BY - Bielorussia 5
CR - Costa Rica 5
EE - Estonia 5
NZ - Nuova Zelanda 5
RS - Serbia 5
SN - Senegal 5
SV - El Salvador 5
HR - Croazia 4
KH - Cambogia 4
LB - Libano 4
MD - Moldavia 4
MK - Macedonia 4
TH - Thailandia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BH - Bahrain 3
CM - Camerun 3
ET - Etiopia 3
Totale 57.561
Città #
Southend 3.738
Moscow 3.168
Chandler 2.472
Dallas 2.126
Singapore 1.837
Ashburn 1.654
Hong Kong 1.390
Jacksonville 1.331
Dublin 1.077
Woodbridge 1.067
Beijing 963
Ann Arbor 960
New York 587
Houston 494
Munich 487
Los Angeles 469
The Dalles 428
Verona 391
Lawrence 367
Princeton 367
Wilmington 345
Jinan 331
Helsinki 284
Ho Chi Minh City 248
Nanjing 248
Shenyang 229
Montréal 195
São Paulo 188
Mcallen 179
Columbus 176
Hebei 175
Milan 175
Buffalo 172
Tokyo 171
Redondo Beach 169
Tianjin 168
Rome 164
Santa Clara 153
Turku 146
Hanoi 135
Sindelfingen 134
Dearborn 131
Zhengzhou 126
Redmond 118
London 113
Seattle 110
Seoul 109
Brussels 107
Ningbo 106
Changsha 104
Denver 96
Boardman 94
Guangzhou 94
Taizhou 94
Bologna 92
Warsaw 91
Brooklyn 89
Haikou 88
Montreal 86
Stockholm 85
Nanchang 80
Orem 78
Frankfurt am Main 75
Redwood City 74
Hangzhou 70
Taiyuan 70
Jiaxing 66
Lancaster 66
Mexico City 66
San Francisco 65
Atlanta 63
Chicago 63
Chennai 62
Lomé 61
Amsterdam 59
Dong Ket 57
Johannesburg 57
Poplar 57
Toronto 56
Rio de Janeiro 53
Cotonou 52
Norwalk 52
Phoenix 52
Volga 47
Belo Horizonte 45
Boston 45
Nuremberg 45
Jakarta 43
Fairfield 39
Vienna 39
Lanzhou 37
Washington 37
Falkenstein 36
Manchester 36
Kent 35
Da Nang 34
Shanghai 34
Ankara 33
Detroit 33
Fuzhou 32
Totale 33.595
Nome #
ARFI Evaluation of Small (<4 cm) Renal Masses. A Preliminary Study 878
I tumori ibridi nell'oncocitosi renale sono l'anello di congiunzione tra oncocitoma renale e il carcinoma renale di tipo cromofobo? 632
Instabilità dei microsatelliti nei carcinomi duttali e nei tumori endocrini del pancreas 353
A re-emerging marker for prognosis in hepatocellular carcinoma: the add-value of fishing c-myc gene for early relapse. 284
A clinical-biological risk stratification model for resected gastric cancer: prognostic impact of Her2, Fhit, and APC expression status 255
Schwannoma del rene 232
The 2012 Briganti nomogram predicts disease progression in surgically treated intermediate-risk prostate cancer patients with favorable tumor grade group eventually associated with some adverse factors 230
Analisi citogenetica in metafase ed interfase nel carcinoma renale cromofobo e nell'onocitoma del rene 228
Comprehensive molecular portrait using next generation sequencing of resected intestinal-type gastric cancer patients dichotomized according to prognosis 224
Breast cancer with both assessment of Her2/Neu overexpression and gene amplification:clinical impact in selecting patients for drug treatment 222
Acquired hemophagocytic syndrome in a patient with synovial sarcoma: a case report 218
ALK gene copy number in lung cancer: Unspecific polyploidy versus specific amplification visible as double minutes 215
True 3q Chromosomal Amplification in Squamous Cell Lung Carcinoma by FISH and aCGH Molecular Analysis: Impact on Targeted Drugs 214
Clinical Factors Predicting and Stratifying the Risk of Lymph Node Invasion in Localized Prostate Cancer 210
ALK/EML4 Fusion Gene May Be Found in Pure Squamous Carcinoma of the Lung 209
Diagnostic utility of S100A1 expression in renal cell neoplasms: an immunohistochemical and quantitative RT-PCR study 209
Adrenal extramedullary hematopoiesis: report on a pediatric case and update of the literature. 207
Low-Risk Prostate Cancer and Tumor Upgrading to Higher Patterns in the Surgical Specimen. Analysis of Clinical Factors Predicting Tumor Upgrading to Higher Gleason Patterns in a Contemporary Series of Patients Who Have Been Evaluated According to the Modified Gleason Score Grading System 207
LC3B and ph-S6K are both expressed in epithelioid and classic renal angiomyolipoma: a rationale tissue-based evidence for combining use of autophagic and mTOR targeted drugs 204
2012 Briganti nomogram predict prostate cancer progression in EAU intermediate risk with unfavorable tumor grade: A single center experience 203
Una complessa valutazione della vitalità delle fratture in ambito forense 201
iPathology cockpit diagnostic station: validation according to College of American Pathologists Pathology and Laboratory Quality Center recommendation at the Hospital Trust and University of Verona 198
Cathepsin K expression in castration-resistant prostate carcinoma: a therapeutical target for patients at risk for bone metastases 198
Prostate Volume Index Associates with a Decreased Risk of Prostate Cancer: Results of a Large Cohort of Patients Elected to a First Biopsy Set 194
Carcinoma a cellule renali associato ad evidente proliferazione stromale leiomiomatosa 192
Clinical factors stratifying the risk of tumor upgrading to high-grade disease in low-risk prostate cancer 192
Carcinomi con traslocazioni coinvolgenti i geni della famiglia MiTF/TFE. 190
Carcinoma a cellule renali di tipo papillare a cellule oncocitiche: studio clinico-patologico di 10 casi. 190
Monosomy of chromosome 17 in breast cancer during interpretation of HER2 gene amplification 190
Adult primary teratoma of the testis--report on 5 cases in clinical stage I disease. 189
8C.05: EPOXYEICOSATRIENOIC ACIDS ARE INCREASED IN PLACENTAS OF PREECLAMPTIC PREGNANCIES 189
An unusual case of Cushing's syndrome due to ACTH-independent macronodular adrenal hyperplasia 188
Digital reporting of whole-slide images is safe and suitable for assessing organ quality in preimplantation renal biopsies 187
Diagnostic utility of S100A1 expression in renal cell neoplasms: an immunohistochemical and quantitative RT-PCR study 186
Consultation between forensic and clinical pathologists for histopathology examination after forensic autopsy 186
ALK gene copy number gains in non-small-cell lung cancer: prognostic impact and clinico-pathological correlations 185
Prostate-specific membrane antigen (PSMA) assembles a macromolecular complex regulating growth and survival of prostate cancer cells "in vitro" and correlating with progression "in vivo" 185
A Novel Prognostic Score based on Serum Alpha-Fetoprotein, Number of Nodules, and MYC Gene Status Predicts Prognosis of Patients after Liver Resection for Hepatocellular Carcinoma 185
Magnitude of PD-1, PD-L1 and T Lymphocyte Expression on Tissue from Castration-Resistant Prostate Adenocarcinoma: An Exploratory Analysis 185
The incidence and relative risk of pulmonary toxicity in patients treated with anti-PD1/PD-L1 therapy for solid tumors: a meta-analysis of current studies 185
Clinical Factors of Disease Reclassification or Progression in a Contemporary Cohort of Prostate Cancer Patients Elected to Active Surveillance 184
CD10 is expressed in a subset of chromophobe renal cell carcinomas 182
Utilità diagnostica della valutazione della ploidia con citometria a flusso nella diagnosi differenziale delle neoplasie a cellule renali 181
Differential Activity of Nivolumab, Pembrolizumab and MPDL3280A according to the Tumor Expression of Programmed Death-Ligand-1 (PD-L1): Sensitivity Analysis of Trials in Melanoma, Lung and Genitourinary Cancers 181
Fast Chromotrope Aniline Blue Special Stain Is a Useful Tool to Assess Fibrosis on Liver Biopsy During Transplantation 180
The preoperative serum ratio of total prostate specific antigen (PSA) to free testosterone (FT), PSA/FT index ratio, and prostate cancer. Results in 220 patients undergoing radical prostatectomy 180
Chondroid syringoma with extensive ossification 180
Adenocarcinoma of the paraurethral glands: a case report 178
Association between Basal Total Testosterone Levels and Tumor Upgrading in Low and Intermediate Risk Prostate Cancer 178
Prognostic impact of proliferation for resected early stage 'pure' invasive lobular breast cancer: Cut-off analysis of Ki67 according to histology and clinical validation 178
Next-generation repeat-free FISH probes for DNA amplification in glioblastoma in vivo: Improving patient selection to MDM2-targeted inhibitors 178
ABO blood group system and risk of positive surgical margins in patients treated with robot-assisted radical prostatectomy: results in 1114 consecutive patients 177
Autophagy pathways in drug abusers after forensic autopsy: LC3B, ph-mTOR and p70S6K analysis 176
Abdominal-aortic atherosclerotic plaque index and perioperative outcomes in partial nephrectomy 175
Oncocytic papillary renal cell carcinoma: potential pitfall in small enucleation. 175
Addressing the best treatment for non-clear cell renal cell carcinoma: A meta-analysis of randomised clinical trials comparing VEGFR-TKis versus mTORi-targeted therapies 175
Chronic Inflammation in Prostate Biopsy Cores is an Independent Factor that Lowers the Risk of Prostate Cancer Detection and is Inversely Associated with the Number of Positive Cores in Patients Elected to a First Biopsy 174
Associations of Transitional Zone Volume with Intraprostatic Chronic Inflammation and Prostate Cancer Risk in Patients Undergoing a First Random Biopsy Set 174
Carcinoma renale a cellule chiare papillare: una distinta entità istopatologica e genetica 172
FGFR-1 amplification in metastatic lymph-nodal and haematogenous lobular breast carcinoma. 171
Reprofiling Metastatic Samples for Chromosome 9p and 14q Aberrations as a Strategy to Overcome Tumor Heterogeneity in Clear-cell Renal Cell Carcinoma 171
Subpopulation Treatment Effect Pattern Plot (STEPP) analysis of Ki67 assay according to histology: prognostic relevance for resected early stage 'pure' and 'mixed' lobular breast cancer 171
Preoperative plasma levels of total testosterone associated with high grade pathology-detected prostate cancer: preliminary results of a prospective study in a contemporary cohort of patients 171
Liver Metastases From Renal Oncocytoma With Vascular Extension 170
Is a Drain Needed after Robotic Radical Prostatectomy with or without Pelvic Lymph Node Dissection? Results of a Single-Center Randomized Clinical Trial 170
Accuracy of on-bench biopsies in the evaluation of the histological subtype, grade, and necrosis of renal tumours 169
A pseudotumoral lesion diagnosed for a hypertrofic fibrosis at the proximal stump in anterior tibialis tendon missed rupture: a case report 169
Adjuvant Chemotherapy For Resected Non-Small-Cell Lung Cancer: Future Perspectives For Clinical Research 169
Extranodal extension of lymph node metastasis influences recurrence in prostate cancer: a systematic review and meta-analysis 168
The Tumor Entity Denominated "clear cell-papillary renal cell carcinoma" According to the WHO 2016 new Classification, have the Clinical Characters of a Renal Cell Adenoma as does Harbor a Benign Outcome 168
Bilateral lymph node micrometastases and seminal vesicle invasion associated with same clinical predictors in localized prostate cancer 168
De Novo Renal Neoplasia After Kidney Transplantation According to New 2016 WHO Classification of Renal Tumors 168
Impact of neoadjuvant single or dual HER2 inhibition and chemotherapy backbone upon pathological complete response in operable and locally advanced breast cancer: Sensitivity analysis of randomized trials 167
Methods to identify molecular expression of mTOR pathway: a rationale approach to stratify patients affected by clear cell renal cell carcinoma for more likely response to mTOR inhibitors. 167
RASSF1 tumor suppressor gene in pancreatic ductal adenocarcinoma: correlation of expression, chromosomal status and epigenetic changes 167
Mesothelial/monocytic incidental cardiac excrescences (MICE): report of a case and review of literature with focus on pathogenesis 167
CARCINOMI DELLA MAMMELLA POSITIVI ALL'IMMUNOESPRESSIONE PER HER-2: VALUTAZIONE CON METODICA FISH DEI CASI CON IMMUNOESPRESSIONE INTRATUMORALE ETEROGENEA 166
Donor kidneys with miliary papillary renal cell neoplasia: the role of the pathologist in determining suitability for transplantation 166
The identification of a small but significant subset of patients still targetable with anti-HER2 inhibitors when affected by triple negative breast carcinoma 166
The Cardiovascular Toxicity of Abiraterone and Enzalutamide in Prostate Cancer 166
[Diagnostic and prognostic markers in renal tumors] 165
Carcinomi della mammella con valutazione dello stato di Her-2 mediante immunoistochimica ed ibridazione in situ fluorescente: impatto clinico nella selezione dei pazienti per la terapia con Herceptin 165
Cathepsin-K immunoreactivity distinguishes MiTF/TFE family renal translocation carcinomas from other renal carcinomas 165
Targeting Met and VEGFR Axis in Metastatic Castration-Resistant Prostate Cancer: 'Game Over'? 165
Acquired cystic disease-associated renal tumors: an immunohistochemical and fluorescence in situ hybridization study 164
Neoadjuvant strategies for triple negative breast cancer: 'state-of-the-art' and future perspectives 163
Consultation interface between Pathologist and Forensic Science Experts for histopathology examination 163
A distinctive translocation carcinoma of the kidney; "rosette forming," t(6;11), HMB45-positive renal tumor: a histomorphologic, immunohistochemical, ultrastructural, and molecular genetic study of 4 cases 162
Molecular heterogeneity assessment by next-generation sequencing and response to gefitinib of EGFR mutant advanced lung adenocarcinoma 162
Ependymoma with diffuse signet-ring features: report of a case and review of the literature 162
Cathepsin-k as a diagnostic marker in the identification of micro-granulomas in Crohn's disease 162
Cortical Expression of the Polysialylated Isoform of the Neural Cell Adhesion Molecule on Brain Tissue to Recognize Drug-Related Death: An Exploratory Analysis 162
[Small cell carcinoma of the bladder. Report of 3 cases and review of the literature] 162
Investigating BRCA Mutations: A Breakthrough in Precision Medicine of Castration-Resistant Prostate Cancer 161
Body Mass Index and prostatic-specific antigen are predictors of prostate cancer metastases in patients undergoing robot-assisted radical prostatectomy and extended pelvic lymph node dissection 160
Her-2/neu evaluation in Sister Mary Joseph's nodule from breast carcinoma: a case report and review of the literature 159
'Case of the Month' from the University of Verona, Italy-navigating the medical and surgical challenges of urinary bladder paraganglioma: insights from a clinical case 159
Original and reviewed nuclear grading according to the Fuhrman system: a multivariate analysis of 338 patients with conventional renal cell carcinoma 158
Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: Heat Shock Protein 90 Overexpression, Ki67 Proliferative Index, and Topoisomerase II-α Co-amplification as Predictors of Pathologic Complete Response to Neoadjuvant Chemotherapy With Trastuzumab and Docetaxel 158
HER2/neu Gene Determination in Women Screened for Breast Carcinoma: How Screening Programs Reduce the Skyrocketing Cost of Targeted Therapy 157
Totale 19.576
Categoria #
all - tutte 201.893
article - articoli 183.664
book - libri 0
conference - conferenze 17.874
curatela - curatele 0
other - altro 355
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 403.786


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.470 0 0 0 0 0 355 105 150 124 62 416 258
2021/20223.076 333 739 51 338 150 132 50 208 93 85 232 665
2022/20237.040 459 772 615 1.188 606 1.737 72 482 765 72 162 110
2023/20244.081 172 300 332 447 481 669 199 246 67 279 638 251
2024/202510.130 507 544 549 1.656 428 351 579 448 1.428 687 983 1.970
2025/202620.348 2.061 1.614 2.351 5.587 8.304 431 0 0 0 0 0 0
Totale 58.553